Obsidian Therapeutics
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| St*** Sh**** | - | - | |
| Ta*** Ka**** | - | - | |
| Mi***** Gi**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Gi**** | - | - |
Funding series
Funding Series Analysis
The company Obsidian Therapeutics has raised a total of $115m in funding over 2 rounds.
Key Insights:
- Obsidian Therapeutics Series B round, September 9, 2021: $115m
- Obsidian Therapeutics Series A round, December 2017: $49.5m
Obsidian Therapeutics Series B round, September 9, 2021
$115m
Obsidian Therapeutics Series A round, December 2017
$49.5m
Industries
Obsidian Therapeutics is active in the following industries: